Health
Team reveals miR-29 as regulator of processes for normal brain maturation – Drug Target Review
Researchers have shown that miR-29 can control brain maturation in mammals, presenting a target for autism, epilepsy and other conditions.
Posted: 7 April 2021 | Victoria Rees (Drug Target Review) | No comments yet
Researchers have shown that miR-29 can control brain maturation in mammals, presenting a target for autism, epilepsy and other conditions.
A team has discovered that a molecule called microRNA-29 (miR-29) is a powerful controller of brain maturation in mammals. The researchers, led by scientists at the University of North Carolina (UNC) School of Medicine, US, say that deleting miR-29 in mice caused problems very similar…
-
General16 hours agoChina and Philippines trade blame over latest South China Sea clash
-
General22 hours agoCalls for government to ‘get on with’ CSIRO Ginninderra Experiment Station land sale after three-year delay
-
Noosa News24 hours agoBetty’s Burgers National Burger Day
-
General16 hours agoSmall plane crashes into San Diego neighbourhood, setting homes and vehicles on fire